HCA Healthcare (NYSE:HCA) Price Target Raised to $507.00 at Leerink Partners

HCA Healthcare (NYSE:HCA) had its price target increased by Leerink Partners from $470.00 to $507.00 in a research report issued on Thursday,MarketScreener reports. The brokerage currently has an “outperform” rating on the stock. Leerink Partners’ price objective suggests a potential upside of 4.92% from the stock’s previous close.

HCA has been the subject of several other reports. Wall Street Zen upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. KeyCorp raised their target price on HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. Stephens lifted their price objective on HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, Wells Fargo & Company raised their target price on HCA Healthcare from $431.00 to $452.00 and gave the company an “equal weight” rating in a research note on Wednesday, January 7th. Fifteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $487.00.

HCA Healthcare Trading Up 0.9%

Shares of NYSE HCA traded up $4.39 during midday trading on Thursday, hitting $483.23. The company’s stock had a trading volume of 1,079,466 shares, compared to its average volume of 948,727. The stock has a fifty day moving average price of $480.39 and a 200 day moving average price of $429.48. The firm has a market capitalization of $110.27 billion, a price-to-earnings ratio of 18.68, a P/E/G ratio of 1.32 and a beta of 1.36. HCA Healthcare has a one year low of $295.00 and a one year high of $520.00.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter last year, the business posted $4.90 earnings per share. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts predict that HCA Healthcare will post 24.98 earnings per share for the current fiscal year.

Insider Transactions at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.30% of the company’s stock.

Institutional Trading of HCA Healthcare

A number of hedge funds have recently bought and sold shares of HCA. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $26,000. Ameriflex Group Inc. bought a new position in shares of HCA Healthcare in the second quarter worth about $27,000. Chung Wu Investment Group LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $27,000. Clearstead Trust LLC boosted its position in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. Finally, Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare in the fourth quarter worth about $29,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.